Problems › Costs Are Rising Faster Than Prices › Accounting & Advisory Firms
A cost squeeze for an accounting firm is an engagement scoping problem as much as a billing rate one. Accounting firms carry a specific bind here — compliance fee compression and inability to shift hours to advisory without reducing statutory output. Until that is priced, 82% realisation rate will keep moving for reasons nobody can attribute, and the debate about input cost pass-through will stay a matter of opinion.
A cost squeeze for an accounting firm is an engagement scoping problem as much as a billing rate one. Accounting firms carry a specific bind here — compliance fee compression and inability to shift hours to advisory without reducing statutory output. Until that is priced, 82% realisation rate will keep moving for reasons nobody can attribute, and the debate about input cost pass-through will stay a matter of opinion.
When staff costs rise faster than fees, the immediate reflex is to cut chargeable hours or push utilisation higher. It is worth doing and it is finite: you can only remove hours once, while compliance output still has to be delivered and advisory work cannot expand without reducing statutory work.
The durable responses are structural. Fee terms tied to a published index rather than to annual negotiation. Shorter engagement letters for advisory work. Repricing at renewal rather than across the book. Changing what is bundled so the fee change lands on advisory services the client is not comparing to last year.
The other half is mix. In most firms the squeeze is not uniform — compliance work absorbs cost pressure while advisory work passes it through more readily — and moving chargeable hours toward advisory is usually faster than winning a fee argument on compliance engagements.
These three together are the signature. One on its own usually points somewhere else.
✓ Realisation rate is falling while chargeable hours hold steady.
✓ Every fee increase requires a fresh discussion with the client.
✓ Engagement letters contain no mechanism for adjusting fees when staff costs rise.
The move that usually makes it worse. Absorbing staff cost increases to protect compliance volume, which trains clients to expect the same fees next year and makes the eventual correction larger.
It is for you if you run or finance an accounting firm and gross margin is falling while volumes hold. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on an accounting firm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Cost & Margin Improvement, one of 29 engagements the platform runs. For accounting firms it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Tie them to something external and verifiable, and give notice. A rise attributed to a published index is a fact; the same rise attributed to your costs is an invitation to negotiate.
Where a credible index exists, it removes the annual argument and usually pays for itself in the first cycle. The work is choosing an index the customer accepts as neutral.
Then the lever is at renewal, and the interim work is mix and cost to serve. It is also the moment to fix the contract, because the same squeeze will happen again.
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית